Eli Lilly (LLY)
(Delayed Data from NYSE)
$762.66 USD
+8.49 (1.13%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $762.65 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 24% (191 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.20 | 2.10 | 9.99 |
Current Quarter Estimate | 2.56 | 37.64 | 59.00 |
Year Ago Quarter Estimate | 1.62 | 11.39 | 50.37 |
Next Quarter Estimate | 2.67 | 34.85 | 60.00 |
Next Year Estimate | 18.33 | 178.47 | 238.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 96.36 | 4.50 | 20.73 |
Next Year | 47.70 | 16.40 | 13.55 |
Last 5 Years | 3.60 | 3.00 | 9.00 |
Next 5 Years | 36.70 | 13.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 119.33 | 15.53 |
Price/Book (MRQ) | 65.90 | 5.42 |
Price/Cash Flow (MRFY) | 98.89 | 11.11 |
Dividend Yield | 0.69% | 2.67% |
Net Profit Margin (TTM) | 15.36% | 13.00% |
Return on Equity (TTM) | 51.22% | 30.19% |
Debt to Equity (MRQ) | 1.69 | 39.80 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.